Cargando…
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
Autores principales: | Ho, Gwendolyn, Dusendang, Jennifer R., Schmittdiel, Julie, Kavecansky, Juraj, Tavakoli, Jahan, Pai, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849957/ https://www.ncbi.nlm.nih.gov/pubmed/33527183 http://dx.doi.org/10.1007/s11239-021-02383-w |
Ejemplares similares
-
Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020) -
Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021) -
Association of Anticoagulant Use with COVID-19 Diagnosis
por: Kavecansky, Juraj, et al.
Publicado: (2020) -
Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
por: Velayos, Fernando S., et al.
Publicado: (2021) -
SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California
por: Anantharaman, Archana, et al.
Publicado: (2020)